Gu Xiaojing, Chen Yongping, Wei Qianqian, Hou Yanbing, Cao Bei, Zhang Lingyu, Ou Ruwei, Lin Junyu, Liu Kuncheng, Zhao Bi, Shang Huifang
Department of Neurology, Laboratory of Neurodegenerative Disorders, Rare Disease Center, West China Hospital, Sichuan University, Chengdu, China.
Front Genet. 2021 Nov 12;12:740052. doi: 10.3389/fgene.2021.740052. eCollection 2021.
CYLD Lysine 63 Deubiquitinase gene () was recently identified to be a novel causative gene for frontal temporal dementia (FTD)-amyotrophic lateral sclerosis (ALS). In the current study, we aimed to (1) systematically screen the mutations of in a large cohort of Chinese ALS patients, (2) study the genotype-phenotype correlation, and (3) explore the role of in ALS rare variants burden analysis. A total of 978 Chinese sporadic ALS (sALS) patients and 46 familial ALS (fALS) patients were sequenced with whole-exome sequencing and analyzed rare variants in with minor allele frequency <0.1%. In total, seven rare missense variants in have been identified in 7 (0.72%) patients among 978 sALS patients. Two (4.3%) rare missense variants were identified among the 46 fALS cases, in which one patient was diagnosed as having comorbidity of ALS and progressive supranuclear palsy (PSP). Moreover, the burden analysis indicated no enrichment of rare variants in among patients with ALS. In conclusion, our study extended the genotype and phenotype of in ALS, but the pathogenicity of these variants needs to be further verified. Moreover, burden analysis argued against the role of in the pathogenesis of ALS. More studies from different ethnicities would be needed.
CYLD赖氨酸63去泛素化酶基因()最近被确定为额颞叶痴呆(FTD)-肌萎缩侧索硬化症(ALS)的一个新的致病基因。在本研究中,我们旨在(1)在一大群中国ALS患者中系统筛查该基因的突变,(2)研究基因型与表型的相关性,以及(3)在ALS罕见变异负担分析中探索该基因的作用。对978例中国散发性ALS(sALS)患者和46例家族性ALS(fALS)患者进行全外显子组测序,并分析该基因中次要等位基因频率<0.1%的罕见变异。在978例sALS患者中,共在7例(0.72%)患者中鉴定出该基因的7个罕见错义变异。在46例fALS病例中鉴定出2个(4.3%)罕见错义变异,其中1例患者被诊断为患有ALS和进行性核上性麻痹(PSP)合并症。此外,负担分析表明ALS患者中该基因的罕见变异没有富集。总之,我们的研究扩展了该基因在ALS中的基因型和表型,但这些变异的致病性需要进一步验证。此外,负担分析反对该基因在ALS发病机制中的作用。需要更多来自不同种族的研究。